by Philippa Shelton | Nov 4, 2022 | Welcome
Isogenica VHH antibodies used in potential therapy for heart failure Our VHH antibodies have been put to the test as a potential new therapy for heart failure in an early-stage study from AstraZeneca published in Nature Communications. In a step forward for...
by Philippa Shelton | Nov 4, 2022 | Press Releases, Welcome
Isogenica and Frederick National Laboratory for Cancer Research team up to discover novel antibody therapeutics Announcing a new collaboration with the Frederick National Laboratory for Cancer Research UK-based antibody engineering experts Isogenica are proud... by Philippa Shelton | Jul 12, 2022 | Welcome
Accelerating antibody discovery with machine learning A collaboration with the University of Nottingham and Aston University Advances in computing and data science, such as machine learning (ML) and artificial intelligence (AI), are transforming all aspects of... by Philippa Shelton | Jul 12, 2022 | Welcome
Creating the next generation of immunotherapies with the University of Leicester Isogenica visiting the team at the University of Leicester Immunotherapy has transformed the cancer treatment landscape in recent years, harnessing the power of the immune system to... by Mandeep Sehmi | Apr 5, 2022 | Welcome
CHI Sixth Annual Immuno-Oncology Summit Europe Join Isogenica in London at the Annunal Immuno-Oncology Summit The Isogenica team will be attending in person at CHI’s annual Immuno-Oncology conference, taking place on 23rd-25th May. Isogenica’s CSO, Dr Bill... by Mandeep Sehmi | Jan 31, 2022 | Welcome
University of Nottingham is inviting applications for a Machine Learning – Antibody Discovery Scientist to join an exciting collaboration with Isogenica. As an enthusiastic graduate, this is a career-development opportunity to manage a Knowledge Transfer...